Asset profile
Docetaxel
Small molecule
Approvedregulatory verdict
Evidence outlook
Approved: HR+/HER2- Metastatic Breast Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
60 competitors in this universe: 0 direct rivals (same mechanism and indication), 0 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Docetaxel: this drug | Approved | Small molecule | Microtubules (tubulin) | ||
| Abemaciclib (Verzenio) | Approved | Small molecule | CDK4 and CDK6 | ||
| Alpelisib (BYL719) | Approved | Small molecule | PI3K-alpha | ||
| Anastrozole | Approved | Small molecule | Aromatase | ||
| Capecitabine | Approved | Small molecule | Fluoropyrimidine (antimetabolite) | ||
| Capivasertib | Approved | Small molecule | AKT (inhibitor) | ||
| Datopotamab Deruxtecan | Approved | Antibody–drug conjugate | TROP2 | ||
| Denosumab | Approved | Monoclonal antibody | RANKL | ||
| Elacestrant | Approved | Small molecule | Estrogen receptor | ||
| Eribulin Mesylate | Approved | Small molecule | Tubulin / microtubules | ||
| Everolimus | Approved | Small molecule | mTOR kinase, mTOR (mTORC1) (inhibitor) | ||
| Exemestane | Approved | Small molecule | Aromatase | ||
| Fulvestrant (Faslodex) | Approved | Small molecule | Estrogen receptor | ||
| Gedatolisib | Approved | Small molecule | PI3K (class I isoforms) and mTORC1/mTORC2 | ||
| Gemcitabine | Approved | Small molecule | ribonucleotide reductase / DNA polymerase (dCTP competition) | ||
| Goserelin | Approved | Peptide | GnRH receptor (agonist) |
…and 45 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(198 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (38)
October 2026 (2)
November 2026 (9)
Phase 2Prostate Cancer MetastaticActive not recruiting
Est. primary completion 2026-11 · NCT03951831 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaActive not recruiting
Est. primary completion 2026-11 · NCT06118333 · CT.gov ↗
What to watch
Phase 1Advanced CancerActive not recruiting
Est. primary completion 2026-11 · NCT06120075 · CT.gov ↗
What to watch
Phase 2Nausea and Vomiting Caused by ChemotherapyRecruiting
Est. primary completion 2026-11 · NCT07537699 · CT.gov ↗
What to watch
Phase 3Gastric Cancer, Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2026-11-01 · NCT04447352 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Peritoneal MetastasisActive not recruiting
Est. primary completion 2026-11-01 · NCT06914687 · CT.gov ↗
What to watch
Phase 3Endometrial NeoplasmsActive not recruiting
Est. primary completion 2026-11-20 · NCT04634877 · CT.gov ↗
What to watch
Phase 1/2Advanced MTAP-null Solid TumorsActive not recruiting
Est. primary completion 2026-11-30 · NCT05094336 · CT.gov ↗
What to watch
Phase 2Lung CancerRecruiting
Est. primary completion 2026-11-30 · NCT06749886 · CT.gov ↗
What to watch
December 2026 (27)
Phase 1Recurrent Non-small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT02889666 · CT.gov ↗
What to watch
Phase 2/3Prostate Cancer PatientsRecruiting
Est. primary completion 2026-12 · NCT03258320 · CT.gov ↗
What to watch
Phase 3Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Recruiting
Est. primary completion 2026-12 · NCT03903835 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2026-12 · NCT05054439 · CT.gov ↗
What to watch
Phase 3Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer …Recruiting
Est. primary completion 2026-12 · NCT05281471 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast Cancer, Breast CancerActive not recruiting
Est. primary completion 2026-12 · NCT05645380 · CT.gov ↗
What to watch
Phase 2Sinonasal Undifferentiated CarcinomaRecruiting
Est. primary completion 2026-12 · NCT05925491 · CT.gov ↗
What to watch
Phase 3Non-small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12 · NCT06382129 · CT.gov ↗
What to watch
Phase 1/2Prostate CancerRecruiting
Est. primary completion 2026-12 · NCT06568094 · CT.gov ↗
What to watch
Phase 1/2Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma, Advanced Solid TumorsRecruiting
Est. primary completion 2026-12 · NCT06943820 · CT.gov ↗
What to watch
Phase 1/2Pediatric Sarcoma, Refractory, Pediatric Sarcoma, RelapsedRecruiting
Est. primary completion 2026-12-01 · NCT05634369 · CT.gov ↗
What to watch
Phase 1/2Metastatic Castration-resistant Prostate CancerRecruiting
Est. primary completion 2026-12-01 · NCT06480110 · CT.gov ↗
What to watch
Phase 3Nausea and Vomiting Caused by ChemotherapyRecruiting
Est. primary completion 2026-12-06 · NCT07716176 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C MutationActive not recruiting
Est. primary completion 2026-12-17 · NCT04185883 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2026-12-24 · NCT06783647 · CT.gov ↗
What to watch
Phase 2Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET OverexpressionNot yet recruiting
Est. primary completion 2026-12-25 · NCT06525350 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumor CancerRecruiting
Est. primary completion 2026-12-30 · NCT07381829 · CT.gov ↗
What to watch
Phase 2/3Gastric CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT01924819 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT04140526 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2026-12-31 · NCT04329065 · CT.gov ↗
What to watch
Phase 1/2Cancer Of Prostate, Prostate NeoplasmsRecruiting
Est. primary completion 2026-12-31 · NCT04633252 · CT.gov ↗
What to watch
Phase 2Bladder Cancer, Non-muscle InvasiveActive not recruiting
Est. primary completion 2026-12-31 · NCT05024734 · CT.gov ↗
What to watch
Phase 3Locally Advanced Gastric Adenocarcinoma, Chemotherapy EffectRecruiting
Est. primary completion 2026-12-31 · NCT05813015 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2026-12-31 · NCT05867420 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2026-12-31 · NCT05978648 · CT.gov ↗
What to watch
Phase 1/2Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8Recruiting
Est. primary completion 2026-12-31 · NCT06704191 · CT.gov ↗
What to watch
Phase 2NSCLC (Non-small Cell Lung Cancer)Recruiting
Est. primary completion 2026-12-31 · NCT07330050 · CT.gov ↗
What to watch
2027 (76)
January 2027 (5)
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-01 · NCT06741644 · CT.gov ↗
What to watch
Phase 1/2Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLCActive not recruiting
Est. primary completion 2027-01 · NCT06879717 · CT.gov ↗
What to watch
Phase 1Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor …Recruiting
Est. primary completion 2027-01-31 · NCT05176483 · CT.gov ↗
What to watch
Phase 2Urinary Bladder CancerActive not recruiting
Est. primary completion 2027-01-31 · NCT05644041 · CT.gov ↗
What to watch
Phase 2Gastric Cancer Stage IIIActive not recruiting
Est. primary completion 2027-01-31 · NCT07257575 · CT.gov ↗
What to watch
February 2027 (2)
Phase 1Solid Tumor, Advanced Cancer, Metastatic Cancer, Non Small Cell Lung Cancer, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma …Recruiting
Est. primary completion 2027-02 · NCT05076760 · CT.gov ↗
What to watch
Phase 1/2Lung Cancer, Non-small Cell, Lung Cancer Metastatic, Solid Tumor, Adult, Advanced Cancer, Lung Cancer (NSCLC)Recruiting
Est. primary completion 2027-02 · NCT06228326 · CT.gov ↗
What to watch
March 2027 (4)
Phase 2Stage IV Prostate Adenocarcinoma AJCC v7Active not recruiting
Est. primary completion 2027-03 · NCT03456843 · CT.gov ↗
What to watch
Phase 2Urothelial CarcinomaActive not recruiting
Est. primary completion 2027-03 · NCT06632951 · CT.gov ↗
What to watch
Phase 1NeoplasmsActive not recruiting
Est. primary completion 2027-03-01 · NCT02817633 · CT.gov ↗
What to watch
Phase 2GC/GEJCNot yet recruiting
Est. primary completion 2027-03-01 · NCT06684158 · CT.gov ↗
What to watch
April 2027 (8)
Phase 3HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2027-04 · NCT04540692 · CT.gov ↗
What to watch
Phase 1/2Locally Advanced Unresectable Esophageal Squamous CarcinomaNot yet recruiting
Est. primary completion 2027-04 · NCT06136988 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-04 · NCT06409390 · CT.gov ↗
What to watch
Phase 3Prostate CancerActive not recruiting
Est. primary completion 2027-04-01 · NCT03574571 · CT.gov ↗
What to watch
Phase 2/3Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma …Recruiting
Est. primary completion 2027-04-25 · NCT06028737 · CT.gov ↗
What to watch
Phase 3Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, PembrolizumabRecruiting
Est. primary completion 2027-04-30 · NCT06102395 · CT.gov ↗
What to watch
Phase 2Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid TumorsRecruiting
Est. primary completion 2027-04-30 · NCT06947291 · CT.gov ↗
What to watch
Phase 2Metastatic Prostate Cancer, Prostate Cancer (Adenocarcinoma), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Not yet recruiting
Est. primary completion 2027-04-30 · NCT07268794 · CT.gov ↗
What to watch
May 2027 (6)
Phase 2Metastatic Castration-resistant Prostate CancerRecruiting
Est. primary completion 2027-05 · NCT05762536 · CT.gov ↗
What to watch
Phase 2Neoplasms, Child, AdolescentRecruiting
Est. primary completion 2027-05 · NCT05999994 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-05 · NCT06928389 · CT.gov ↗
What to watch
Phase 2Lung CancerRecruiting
Est. primary completion 2027-05-30 · NCT06421298 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, Gastroesophageal Junction AdenocarcinomaActive not recruiting
Est. primary completion 2027-05-31 · NCT03421288 · CT.gov ↗
What to watch
Phase 1/2Recurrent Osteosarcoma, Refractory OsteosarcomaActive not recruiting
Est. primary completion 2027-05-31 · NCT03598595 · CT.gov ↗
What to watch
June 2027 (8)
Phase 1Gastroesophageal AdenocarcinomaRecruiting
Est. primary completion 2027-06 · NCT05733689 · CT.gov ↗
What to watch
Phase 1/2Non Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT07070440 · CT.gov ↗
What to watch
Phase 2Prostate CancerRecruiting
Est. primary completion 2027-06-01 · NCT04812366 · CT.gov ↗
What to watch
Early phase / not applicablePathological and Imaging Examinations Confirmed Metastatic Prostate CancerEnrolling by invitation
Est. primary completion 2027-06-10 · NCT07112209 · CT.gov ↗
What to watch
Phase 1Head and Neck Cancer, Head Cancer, Head Cancer Neck, Neck Cancer, Head and Neck Squamous Cell Carcinoma, HNSCCRecruiting
Est. primary completion 2027-06-20 · NCT04722523 · CT.gov ↗
What to watch
Phase 2Neoplasm MetastasisActive not recruiting
Est. primary completion 2027-06-30 · NCT00781612 · CT.gov ↗
What to watch
Phase 2Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin …Active not recruiting
Est. primary completion 2027-06-30 · NCT03505320 · CT.gov ↗
What to watch
Phase 2Stomach NeoplasmRecruiting
Est. primary completion 2027-06-30 · NCT05184803 · CT.gov ↗
What to watch
July 2027 (1)
Phase 2Prostate Cancer, Stage IV Prostate CancerActive not recruiting
Est. primary completion 2027-07-15 · NCT05189457 · CT.gov ↗
What to watch
August 2027 (5)
Phase 2Bladder CancerRecruiting
Est. primary completion 2027-08 · NCT06488222 · CT.gov ↗
What to watch
Phase 4HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-08-01 · NCT07093931 · CT.gov ↗
What to watch
Phase 1/2Non-small Cell Lung CancerRecruiting
Est. primary completion 2027-08-31 · NCT05777278 · CT.gov ↗
What to watch
Phase 1Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate CancerRecruiting
Est. primary completion 2027-08-31 · NCT05818683 · CT.gov ↗
What to watch
Phase 2Non Small Cell Lung CancerRecruiting
Est. primary completion 2027-08-31 · NCT07306624 · CT.gov ↗
What to watch
September 2027 (5)
Phase 1/2Advanced Solid Tumors, Genital Neoplasm, Female, Urogenital Neoplasms, Lung Neoplasm, Neoplasms by Site, Papillomavirus Infection …Recruiting
Est. primary completion 2027-09 · NCT05592626 · CT.gov ↗
What to watch
Phase 2Gastroesophageal Junction Adenocarcinoma, Gastric AdenocarcinomaActive not recruiting
Est. primary completion 2027-09 · NCT07776639 · CT.gov ↗
What to watch
Phase 3Esophageal Squamous Cell Carcinoma (ESCC)Enrolling by invitation
Est. primary completion 2027-09-01 · NCT07016737 · CT.gov ↗
What to watch
Phase 1/2Soft Tissue Sarcoma, Sarcoma,Soft Tissue, Sarcoma, Soft Tissue Sarcoma AdultRecruiting
Est. primary completion 2027-09-29 · NCT04577014 · CT.gov ↗
What to watch
Phase 2Metastatic Non Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT04884282 · CT.gov ↗
What to watch
October 2027 (5)
Early phase / not applicableCarcinoma, Non-Small-Cell LungRecruiting
Est. primary completion 2027-10-01 · NCT06484491 · CT.gov ↗
What to watch
Phase 1Gastro-esophageal Junction (GEJ) Cancer, Esophagus CancerRecruiting
Est. primary completion 2027-10-01 · NCT07700420 · CT.gov ↗
What to watch
Phase 1/2Metastatic Castration-Resistant Prostate CancerActive not recruiting
Est. primary completion 2027-10-22 · NCT02861573 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2027-10-31 · NCT04266249 · CT.gov ↗
What to watch
Phase 1Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8 …Recruiting
Est. primary completion 2027-10-31 · NCT04615013 · CT.gov ↗
What to watch
November 2027 (6)
Early phase / not applicableHypopharyngeal CarcinomaRecruiting
Est. primary completion 2027-11 · NCT05494190 · CT.gov ↗
What to watch
Phase 2Non Muscle Invasive Bladder CancerRecruiting
Est. primary completion 2027-11 · NCT06663137 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2027-11-01 · NCT07059611 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-11-14 · NCT07220135 · CT.gov ↗
What to watch
Phase 3Prostatic Neoplasms, Castration-ResistantRecruiting
Est. primary completion 2027-11-19 · NCT07225946 · CT.gov ↗
What to watch
Phase 2Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene MutationRecruiting
Est. primary completion 2027-11-30 · NCT06123338 · CT.gov ↗
What to watch
December 2027 (21)
Phase 1/2Non Small Cell Lung Cancer, Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2027-12 · NCT05431270 · CT.gov ↗
What to watch
Phase 2Advanced Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-12 · NCT05676931 · CT.gov ↗
What to watch
Phase 3Metastatic Castration-resistant Prostate CancerRecruiting
Est. primary completion 2027-12 · NCT06520345 · CT.gov ↗
What to watch
Phase 2TNBC, TNBC - Triple-Negative Breast Cancer, Early Stage Triple-Negative Breast CarcinomaRecruiting
Est. primary completion 2027-12 · NCT07017673 · CT.gov ↗
What to watch
Phase 1HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12 · NCT07358806 · CT.gov ↗
What to watch
Phase 1/2Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma …Recruiting
Est. primary completion 2027-12-01 · NCT05910827 · CT.gov ↗
What to watch
Phase 1Prostate CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT07516704 · CT.gov ↗
What to watch
Phase 2/3Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2027-12-15 · NCT05063552 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumorRecruiting
Est. primary completion 2027-12-15 · NCT07669415 · CT.gov ↗
What to watch
Phase 2Non-small-cell Lung CancerRecruiting
Est. primary completion 2027-12-30 · NCT06141226 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-12-31 · NCT01154920 · CT.gov ↗
What to watch
Phase 2Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Peritoneal CarcinomatosisRecruiting
Est. primary completion 2027-12-31 · NCT04840264 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma …Recruiting
Est. primary completion 2027-12-31 · NCT05726370 · CT.gov ↗
What to watch
Phase 2/3Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2027-12-31 · NCT06616584 · CT.gov ↗
What to watch
Phase 1/2Stomach Neoplasm, Gastric (Stomach) CancerRecruiting
Est. primary completion 2027-12-31 · NCT06732856 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck CancerRecruiting
Est. primary completion 2027-12-31 · NCT07214987 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT07246317 · CT.gov ↗
What to watch
Phase 2HER2-positive Early-stage Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT07402473 · CT.gov ↗
What to watch
Phase 2NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)Recruiting
Est. primary completion 2027-12-31 · NCT07528274 · CT.gov ↗
What to watch
Phase 2Recurrent Head and Neck Squamous Cell Carcinoma, Head and Neck CancerEnrolling by invitation
Est. primary completion 2027-12-31 · NCT07618624 · CT.gov ↗
What to watch
2028 (32)
January 2028 (3)
Phase 2/3NPC, HNSCC, Recurrence, MetastasisNot yet recruiting
Est. primary completion 2028-01-01 · NCT06719479 · CT.gov ↗
What to watch
Phase 2HER2-positive Breast Cancer, Breast CancerRecruiting
Est. primary completion 2028-01-01 · NCT07102381 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma of the Head and Neck, Oropharynx, Human Papillomavirus Viruses, Drug Therapy, Cancer VaccineActive not recruiting
Est. primary completion 2028-01-10 · NCT06223568 · CT.gov ↗
What to watch
February 2028 (2)
March 2028 (3)
Phase 3Metastatic Castration Resistant Prostate CancerRecruiting
Est. primary completion 2028-03 · NCT07723248 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma, the Nasal Cavity, Paranasal SinusesRecruiting
Est. primary completion 2028-03-30 · NCT05027633 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-03-31 · NCT07824869 · CT.gov ↗
What to watch
April 2028 (1)
Phase 1/2Metastatic Castration-resistant Prostate Cancer (mCRPC)Recruiting
Est. primary completion 2028-04 · NCT06615752 · CT.gov ↗
What to watch
June 2028 (8)
Phase 2Breast Cancer, HER2-positive Breast CancerRecruiting
Est. primary completion 2028-06 · NCT06441890 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-06-01 · NCT07805135 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2028-06-15 · NCT05296798 · CT.gov ↗
What to watch
Phase 3Gastric Cancer, Adjuvant Chemotherapy, XORecruiting
Est. primary completion 2028-06-30 · NCT01935778 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2028-06-30 · NCT04437329 · CT.gov ↗
What to watch
Phase 3Non-muscle Invasive Bladder Cancer With Carcinoma in SituRecruiting
Est. primary completion 2028-06-30 · NCT06545955 · CT.gov ↗
What to watch
Phase 1Advanced Non-small Cell Lung CancerRecruiting
Est. primary completion 2028-06-30 · NCT06868732 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-06-30 · NCT07797218 · CT.gov ↗
What to watch
July 2028 (3)
Phase 1Muscle Invasive Bladder Urothelial CarcinomaEnrolling by invitation
Est. primary completion 2028-07-01 · NCT06204614 · CT.gov ↗
What to watch
Phase 2Non Small Cell Lung Cancer, Immune Checkpoint Inhibitors (ICIs)Recruiting
Est. primary completion 2028-07-01 · NCT06951646 · CT.gov ↗
What to watch
Phase 2Salivary Gland Carcinoma, Precision TherapyRecruiting
Est. primary completion 2028-07-10 · NCT06145308 · CT.gov ↗
What to watch
August 2028 (4)
Phase 3Triple-negative Breast CancerNot yet recruiting
Est. primary completion 2028-08 · NCT06795503 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-08 · NCT07102940 · CT.gov ↗
What to watch
Phase 2Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung CancerRecruiting
Est. primary completion 2028-08-01 · NCT05800587 · CT.gov ↗
What to watch
Phase 2Locally Advanced Sinonasal CarcinomaNot yet recruiting
Est. primary completion 2028-08-01 · NCT07645846 · CT.gov ↗
What to watch
September 2028 (1)
Phase 3NSCLC Stage IVRecruiting
Est. primary completion 2028-09 · NCT06745908 · CT.gov ↗
What to watch
October 2028 (2)
November 2028 (1)
Phase 2Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical SiteNot yet recruiting
Est. primary completion 2028-11-30 · NCT07547592 · CT.gov ↗
What to watch
December 2028 (4)
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2028-12-25 · NCT06682780 · CT.gov ↗
What to watch
Phase 1/2Urothelial Carcinoma, Bladder CancerActive not recruiting
Est. primary completion 2028-12-31 · NCT03317158 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2028-12-31 · NCT05382559 · CT.gov ↗
What to watch
Phase 2Advanced Prostate CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT07730580 · CT.gov ↗
What to watch
2029 (26)
January 2029 (3)
Phase 2Metastatic Castration Sensitive Prostate CancerActive not recruiting
Est. primary completion 2029-01 · NCT06734130 · CT.gov ↗
What to watch
Phase 1/2Prostatic Neoplasms, Castration-ResistantRecruiting
Est. primary completion 2029-01-15 · NCT06353386 · CT.gov ↗
What to watch
Phase 2/3Resectable MMR-deficient Solid Tumors, Resectable MMR-proficient Solid TumorsRecruiting
Est. primary completion 2029-01-29 · NCT06279130 · CT.gov ↗
What to watch
February 2029 (1)
Phase 1/2Non-Small Cell Lung Cancer, Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-02-28 · NCT07472647 · CT.gov ↗
What to watch
March 2029 (2)
Phase 1Advanced Solid Tumor, Metastatic Solid Tumor, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma …Recruiting
Est. primary completion 2029-03 · NCT06266299 · CT.gov ↗
What to watch
Phase 2Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7Active not recruiting
Est. primary completion 2029-03-31 · NCT03493425 · CT.gov ↗
What to watch
April 2029 (3)
Phase 2Gastroesophageal AdenocarcinomaNot yet recruiting
Est. primary completion 2029-04 · NCT07625930 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma (mPDAC), Advanced Solid TumorsNot yet recruiting
Est. primary completion 2029-04 · NCT07699757 · CT.gov ↗
What to watch
Phase 3Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2029-04-30 · NCT06632327 · CT.gov ↗
What to watch
May 2029 (3)
Phase 1Advanced Solid TumorRecruiting
Est. primary completion 2029-05-01 · NCT06241456 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2029-05-01 · NCT07527806 · CT.gov ↗
What to watch
Phase 2Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 …Recruiting
Est. primary completion 2029-05-25 · NCT06078709 · CT.gov ↗
What to watch
June 2029 (3)
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-06 · NCT05901428 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast CancerRecruiting
Est. primary completion 2029-06 · NCT06291064 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung CanceNot yet recruiting
Est. primary completion 2029-06-01 · NCT07361484 · CT.gov ↗
What to watch
July 2029 (1)
Phase 2Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8Recruiting
Est. primary completion 2029-07-05 · NCT07698535 · CT.gov ↗
What to watch
August 2029 (1)
Phase 2Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Urothelial Carcinoma, Head and Neck Squamous Cell Carcinoma, Merkel Cell Carcinoma …Active not recruiting
Est. primary completion 2029-08-31 · NCT03228667 · CT.gov ↗
What to watch
September 2029 (2)
Phase 2Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 …Recruiting
Est. primary completion 2029-09-06 · NCT05541016 · CT.gov ↗
What to watch
Phase 3Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate CancerRecruiting
Est. primary completion 2029-09-30 · NCT06439225 · CT.gov ↗
What to watch
October 2029 (1)
Phase 2Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid TumorRecruiting
Est. primary completion 2029-10-01 · NCT07246863 · CT.gov ↗
What to watch
November 2029 (1)
Phase 3Non-muscle-invasive Bladder CancerActive not recruiting
Est. primary completion 2029-11-01 · NCT05538663 · CT.gov ↗
What to watch
December 2029 (5)
Phase 3Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) …Not yet recruiting
Est. primary completion 2029-12 · NCT07464145 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumor, Metastatic Solid Tumor, Advanced and/or Metastatic Solid TumorsNot yet recruiting
Est. primary completion 2029-12-30 · NCT06724042 · CT.gov ↗
What to watch
Phase 2Non-Muscle-Invasive Bladder Cancer, BCG-Unresponsive Bladder CancerRecruiting
Est. primary completion 2029-12-30 · NCT07747740 · CT.gov ↗
What to watch
Phase 2Non Muscle Invasive Bladder CancerRecruiting
Est. primary completion 2029-12-31 · NCT06972615 · CT.gov ↗
What to watch
Phase 2Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2029-12-31 · NCT07354984 · CT.gov ↗
What to watch
2030 (10)
February 2030 (1)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-02 · NCT05142189 · CT.gov ↗
What to watch
March 2030 (3)
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2030-03-20 · NCT06042569 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2030-03-30 · NCT06439693 · CT.gov ↗
What to watch
Phase 3Metastatic Hormone-sensitive Prostate CancerRecruiting
Est. primary completion 2030-03-31 · NCT07333066 · CT.gov ↗
What to watch
April 2030 (1)
Phase 1Advanced Solid TumorsRecruiting
Est. primary completion 2030-04-30 · NCT05719558 · CT.gov ↗
What to watch
June 2030 (1)
Phase 2Gastroesophageal Junction (GEJ) AdenocarcinomaRecruiting
Est. primary completion 2030-06 · NCT07018570 · CT.gov ↗
What to watch
July 2030 (1)
Phase 2/3Prostate CancerRecruiting
Est. primary completion 2030-07-31 · NCT06282588 · CT.gov ↗
What to watch
August 2030 (1)
Phase 1Advanced Solid TumorsRecruiting
Est. primary completion 2030-08-31 · NCT05954312 · CT.gov ↗
What to watch
November 2030 (1)
Phase 2Bladder Cancer, Non-muscle Invasive Bladder Cancer, Low GradeNot yet recruiting
Est. primary completion 2030-11-30 · NCT06227065 · CT.gov ↗
What to watch
December 2030 (1)
Phase 3NSCLC (Non-small Cell Lung Carcinoma), First Line Therapy, Locally Advanced/Metastatic NSCLCRecruiting
Est. primary completion 2030-12-31 · NCT07050043 · CT.gov ↗
What to watch
2031 (9)
March 2031 (2)
Phase 1Non-Small Cell Lung Cancer, Pancreatic Cancer, Locally Advanced Solid Tumor, Metastatic Solid TumorActive not recruiting
Est. primary completion 2031-03-01 · NCT05919537 · CT.gov ↗
What to watch
Phase 3Prostate Cancer (Adenocarcinoma)Recruiting
Est. primary completion 2031-03-14 · NCT06592924 · CT.gov ↗
What to watch
April 2031 (1)
Phase 3Prostate Cancer MetastaticRecruiting
Est. primary completion 2031-04 · NCT06320067 · CT.gov ↗
What to watch
July 2031 (1)
Phase 3HER2 Positive Early Breast CancerRecruiting
Est. primary completion 2031-07-01 · NCT05883852 · CT.gov ↗
What to watch
August 2031 (1)
Phase 1/2Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer …Recruiting
Est. primary completion 2031-08-31 · NCT04895709 · CT.gov ↗
What to watch
November 2031 (2)
Phase 3Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2031-11-07 · NCT03801876 · CT.gov ↗
What to watch
Phase 3Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8Recruiting
Est. primary completion 2031-11-11 · NCT06931340 · CT.gov ↗
What to watch
2032 (3)
May 2032 (1)
Phase 3Endometrial CancerRecruiting
Est. primary completion 2032-05-24 · NCT06952504 · CT.gov ↗
What to watch
August 2032 (1)
Phase 2Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Not yet recruiting
Est. primary completion 2032-08 · NCT07645326 · CT.gov ↗
What to watch
December 2032 (1)
Phase 2Breast Cancer, Triple Negative Breast CancerNot yet recruiting
Est. primary completion 2032-12 · NCT07743632 · CT.gov ↗
What to watch
2033 (2)
January 2033 (1)
Phase 2Bladder Cancer, Non-Muscle Invasive Bladder Cancer (NMIBC), Urothelial Carcinoma, Carcinoma in Situ (CIS) …Recruiting
Est. primary completion 2033-01-01 · NCT07322263 · CT.gov ↗
What to watch
March 2033 (1)
Phase 3Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 …Recruiting
Est. primary completion 2033-03-31 · NCT05929768 · CT.gov ↗
What to watch
2034 (1)
July 2034 (1)
Phase 2Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2-positive Breast Cancer, Breast CancerRecruiting
Est. primary completion 2034-07-01 · NCT06348134 · CT.gov ↗
What to watch
2036 (1)
October 2036 (1)
Phase 1/2Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Paranasal Sinus Neoplasms, Nasopharyngeal Carcinoma …Not yet recruiting
Est. primary completion 2036-10-01 · NCT07667400 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.